Cargando…

TMSB4X: A novel prognostic marker for non-small cell lung cancer

Non-small cell lung cancer (NSCLC), as the main type of lung cancer, has a long history of high incidence and mortality. Despite the continuous updates to the American Joint Committee on Cancer (AJCC) staging system, which adapt to evolving treatment modalities and diagnostic advancements, it is evi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ze, Luo, Jihang, Zhang, Mengmei, Zhan, Meixiao, Bai, Yuju, Yang, Yi, Wang, Wei, Lu, Ligong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663839/ https://www.ncbi.nlm.nih.gov/pubmed/38027718 http://dx.doi.org/10.1016/j.heliyon.2023.e21505

Ejemplares similares

miR-183 promotes radioresistance of lung adenocarcinoma H1299 cells via epithelial-mesenchymal transition
por: Huang, Yi, et al.
Publicado: (2021)

TMSB4 Overexpression Enhances the Potency of Marrow Mesenchymal Stromal Cells for Myocardial Repair
por: Tang, Shiyuan, et al.
Publicado: (2021)

Tmsb10 triggers fetal Leydig differentiation by suppressing the RAS/ERK pathway
por: Inoue, Miki, et al.
Publicado: (2022)

Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma
por: Xiong, Ye, et al.
Publicado: (2022)

Changes in Biomechanical Properties of A375 Cells Due to the Silencing of TMSB4X Expression Are Not Directly Correlated with Alterations in Their Stemness Features
por: Makowiecka, Aleksandra, et al.
Publicado: (2021)

Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming
por: Wu, Yunjian, et al.
Publicado: (2022)

TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma
por: Pan, Qiufeng, et al.
Publicado: (2020)

TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer
por: Wong, Hong Yuen, et al.
Publicado: (2015)

Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis
por: Luo, Jihang, et al.
Publicado: (2020)

The Value of MicroRNA-155 as a Prognostic Factor for Survival in Non-Small Cell Lung Cancer: A Meta-Analysis
por: Wang, Fei, et al.
Publicado: (2015)

Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer
por: Darb-Esfahani, S, et al.
Publicado: (2012)

The TMSB4 Pseudogene LncRNA Functions as a Competing Endogenous RNA to Promote Cartilage Degradation in Human Osteoarthritis
por: Liu, Qiang, et al.
Publicado: (2016)

LINC02678 as a Novel Prognostic Marker Promotes Aggressive Non-small-cell Lung Cancer
por: Jia, Dexin, et al.
Publicado: (2021)

Preoperative splenic area as a prognostic biomarker of early-stage non-small cell lung cancer
por: Liu, Mengmei, et al.
Publicado: (2023)

CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer
por: Sun, Lichao, et al.
Publicado: (2016)

CHID1 Is a Novel Prognostic Marker of Non-Small Cell Lung Cancer
por: Kovaleva, Olga V., et al.
Publicado: (2021)

Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myeloma
por: Tantawy, Marwa, et al.
Publicado: (2023)

Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data
por: Liu, Shaoqing, et al.
Publicado: (2021)

Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study
por: Gozzard, Paul, et al.
Publicado: (2015)

Circular RNA PIP5K1A (circPIP5K1A) accelerates endometriosis progression by regulating the miR-153-3p/Thymosin Beta-4 X-Linked (TMSB4X) pathway
por: Sun, Lin, et al.
Publicado: (2021)

DNMT1 maintains the methylation of miR‐152‐3p to regulate TMSB10 expression, thereby affecting the biological characteristics of colorectal cancer cells
por: Wang, Chenchen, et al.
Publicado: (2020)

miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1
por: Hua, Shengni, et al.
Publicado: (2019)

Near-infrared light-triggered nano-prodrug for cancer gas therapy
por: Liu, Runcong, et al.
Publicado: (2021)

Prognostic and Predictive Role of Angiogenic Markers in Non- Small Cell Lung Cancer
por: Keskin, Serkan, et al.
Publicado: (2019)

Novel image markers for non-small cell lung cancer classification and survival prediction
por: Wang, Hongyuan, et al.
Publicado: (2014)

Successful treatment of brain radiation necrosis resulting from triple-negative breast cancer with Endostar and short-term hyperbaric oxygen therapy: a case report
por: Xing, Shiyun, et al.
Publicado: (2019)

Hypoxia-degradable and long-circulating zwitterionic phosphorylcholine-based nanogel for enhanced tumor drug delivery
por: Peng, Shaojun, et al.
Publicado: (2021)

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
por: Hou, Xiaoying, et al.
Publicado: (2022)

Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy
por: Zhan, Meixiao, et al.
Publicado: (2022)

Self‐Splittable Transcytosis Nanoraspberry for NIR‐II Photo‐Immunometabolic Cancer Therapy in Deep Tumor Tissue
por: Wang, Li, et al.
Publicado: (2022)

Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
por: Jiang, Lei, et al.
Publicado: (2023)

EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer
por: Fang, Shu, et al.
Publicado: (2014)

INSL4 as prognostic marker for proliferation and invasiveness in Non-Small-Cell Lung Cancer
por: Scopetti, Damiano, et al.
Publicado: (2021)

Zinc finger protein 703 induces EMT and sorafenib resistance in hepatocellular carcinoma by transactivating CLDN4 expression
por: Wang, Hao, et al.
Publicado: (2020)

Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma
por: Xiaochun, Huang, et al.
Publicado: (2022)

Eosinophil and IFN-γ associated with immune-related adverse events as prognostic markers in patients with non-small cell lung cancer treated with immunotherapy
por: Hu, Wei-Ting, et al.
Publicado: (2023)

ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer
por: Shimizu, K, et al.
Publicado: (2014)

SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker
por: Xu, Liyun, et al.
Publicado: (2018)

SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma
por: Xu, Hongfa, et al.
Publicado: (2020)

Diagnostic and prognostic validity of serum bone turnover markers in bone metastatic non-small cell lung cancer patients
por: Wang, Zhiyu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3o01dhcmimil90f6383s7qihne